Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis

被引:0
作者
Jon-Magnus Tangen
Geir Erland Tjønnfjord
Nina Gulbrandsen
Tobias Gedde-Dahl
Espen Stormorken
Kristina Anderson
Camilla Dao Vo
Fredrik Hellem Schjesvold
机构
[1] Oslo University Hospital,Department of Acute Medicine
[2] Oslo University Hospital,Department of Haematology
[3] University of Oslo,Institute of Clinical Medicine
[4] Akershus University Hospital,Department of Haematology
[5] Section of Haematology,Department of Oncology
[6] Østfold Hospital,Department of Medicine
[7] Innlandet Hospital,undefined
来源
BMC Cancer | / 18卷
关键词
Multiple myeloma; Autologous stem cell transplantation; Overall survival; Novel drugs;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 122 条
[1]  
Röllig C(2015)Multiple myeloma Lancet 385 2197-2208
[2]  
Knop S(1998)Combination chemotherapy plus prednisone as treatment for multiple myeloma. An overview of 6.633 patients from 27 randomized trials J Clin Oncol 16 3832-3842
[3]  
Bornhaüser M(1996)A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med 335 91-97
[4]  
Attal M(2003)High dose chemotherapy with hematopoetic stem-cell rescue for multiple myeloma N Engl J Med 348 1875-1883
[5]  
Harrousseau JL(2007)High dose treatment with autologous stem cell transplantation in multiple myeloma: past, present and future Semin Hematol 44 227-233
[6]  
Stoppa AM(2001)Health-related quality of life in multiple myeloma receiving high dose chemotherapy with autologous blood stem- cell support Med Oncol 18 65-77
[7]  
Sotto JJ(2006)Intensive therapy for multiple myeloma in patients younger than 60 years. Long term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation Haematologica 91 1228-1233
[8]  
Fuzibet JG(2006)Nordic myeloma study group. Impact of age on survival of intensive therapy for multiple myeloma: a population based study by the Nordic myeloma study group Br J Haematol 133 389-396
[9]  
Rossi JF(1999)Antitumor activity of thalidomide in refractory multiple myeloma N Engl J Med 341 1565-1571
[10]  
Child JA(2003)A phase II study of bortezomib in relapsed, refractory myeloma N Engl J Med 348 2609-2617